Author Interviews, Stem Cells / 07.10.2025

Editor's note: Stem cell treatments are generally not FDA tested or approved. Providers and clinics from countries outside the United States may have different safety standards than those in the US. Please note that statements and clinics made in this post are not independently verified or warranted by MedicalResearch.com or Eminent Domains Inc.  Please consult with your health care provider to direct your treatment. [caption id="attachment_70907" align="aligncenter" width="500"] Why Stem Cell Therapy Requires Certified Medical Experts Photo by Mikhail Nilov[/caption] Stem cell therapy is an amazing new treatment in modern medicine. It gives real hope to people specially who suffer from long-term pain or injuries that normal treatments cannot fix. But because it is becoming more popular, many doctors without proper training are now offering it. This is dangerous. It means that only certified medical experts should perform stem cell therapy. If you want treatment for arthritis, brain problem or any spinal cord injury, it is very important that your doctors are well qualified and experienced. In today’s blog, we look at five main reasons why trained professionals are so important for your safety and long-term healing in stem cell therapy!

1. Certified Experts Ensure Safety and Ethical Practice

Stem cell therapy uses special cells that help your body heal itself. These powerful cells can change into many types of tissues. These can be nerve, bone, muscle or blood. It depends on how they are used. This process is complex. Even a small mistake in injecting the cells can lead to serious problems. Later, it can cause infection and tissue damage and make your body rejecting the cells. Certified medical experts know how to handle stem cells safely. They follow strict rules at every step. They always work in sterile rooms and use modern imaging machines to guide the injections. So, if you are thinking about getting stem cell therapy in another country consider a trusted and certified clinic like R3 Stem Cell Mexico. Here expert doctors and labs work together to help keep you safe.  
Author Interviews, Cancer Research, Colon Cancer, Stem Cells / 14.02.2025

MedicalResearch.com Interview with: [caption id="attachment_66601" align="alignleft" width="200"]Slim Mzoughi, PhD Assistant Professor Icahn School of Medicine at Mount Sinai Department of Oncological Sciences Hess Center for Science and Medicine New York, NY 10029 Dr. Mzoughi[/caption] Slim Mzoughi, PhD Assistant Professor Icahn School of Medicine at Mount Sinai Department of Oncological Sciences Hess Center for Science and Medicine New York, NY 10029 MedicalResearch.com: What is the background for this study? Response: Resistance to current cancer treatments remains one of the biggest challenges in oncology, often leading to cancer recurrence even after patients appear to be in remission. To overcome this obstacle, we first need to understand the mechanisms behind this resistance. For a long time, treatment resistance in colorectal cancer (CRC)—the second deadliest cancer worldwide—has been attributed to a specific group of cells known as LGR5+ cancer stem cells. However, recent studies suggest that simply targeting these cells is insufficient for achieving long-term cancer control. That’s where our study comes in—to uncover why this is the case. MedicalResearch.com:  What are the main findings? Response:  Our study reveals that, early in tumor formation, LGR5+ cancer stem cells undergo molecular changes that render them unrecognizable. These changes cause them to resemble those found in the developing fetal intestine. In a way, this transformation reminds me of the legend of Edward Mordake, where these now fetal-like cells act as the “demon face” of cancer stem cells, resisting and surviving treatment. Crucially, we have identified the mechanism driving this reversion to a fetal-like state, which we term oncofetal-reprogramming. Excitingly, when we targeted the oncofetal cell state alongside existing chemotherapy treatments, this significantly enhanced treatment effectiveness and extended survival in preclinical models, offering new hope for CRC patients.
Pain Research, Stem Cells / 12.12.2024

back-pain-stem-cells

Why is Stem Cell Therapy for Back Pain a Revolutionary Approach?

Data on chronic back pain expose the shockingly global frequency of this disorder. Global studies estimate that back pain is one of the most frequent musculoskeletal conditions affecting around 540 million people at any one time. In contemporary life, bad posture, inactive behavior, and lack of consistent exercise help to explain the growing back pain frequency. Furthermore, aggravating the problem are elements like heavy lifting, repeated actions, and stress. While many people find relief from conventional therapies including medicine and physical therapy, new developments in medical science offer encouraging answers. Stem treatment for back pain is one such cutting-edge method that uses stem cells' capacity for regeneration to heal damaged tissues and reduce persistent pain. Offering those with crippling back pain a chance to restore mobility, comfort, and an enhanced quality of life, this innovative therapy has huge potential to change their life. Offering hope and healing for those with chronic back pain, stem cell therapy has become a breakthrough substitute in the world of medical science in recent years. Stem treatment for back pain employs stem cells' regenerative capacity to target pain's underlying causes and advance tissue healing. Stem cells are injected into the afflicted location in this novel treatment; they have the amazing capacity to develop into various kinds of cells and rebuild damaged tissues. Stem cell treatment for back pain has the ability to give long-lasting relief and enhance the general quality of life for people suffering with this crippling illness by encouraging the body's natural healing process. As the research on using stem cells for lower back advances constantly, this innovative treatment presents a potentially viable path for people looking for a quick and transforming fix for their back discomfort.
Dermatology / 17.05.2024

Our skin is subject to a multitude of internal and external influences that can affect its thickness and texture over time. Factors such as aging, environmental aggressors, lifestyle choices, and genetics can contribute to the gradual thinning and deterioration of skin quality. However, the good news is that there are various approaches to address these concerns and promote the restoration of skin thickness and texture. In this article, we'll explore a few crucial factors that, according to research, play pivotal roles in this rejuvenation process.

The Proliferation and Migration of Skin Cells

skin-care-dermatologyAccording to the National Institutes of Health, at the core of skin thickness and texture restoration lies the process of cell proliferation and migration. The epidermis, the outermost layer of the skin, constantly undergoes renewal through a process known as epidermal turnover. Stem cells within the basal layer of the epidermis divide and differentiate into keratinocytes. These gradually migrate upward to the skin's surface, replacing old, damaged cells. According to Beyond CellCare, stem cell therapy differs from traditional treatments, which only target the symptoms of skin aging. By fostering cellular repair and renewal, it targets the fundamental mechanisms of aging. Furthermore, certain skincare ingredients and treatments, such as chemical exfoliants and professional procedures like microdermabrasion and chemical peels, can accelerate cell turnover. You’ll also find the use of exosome injection and similar therapy methods involving exosomes becoming popular in this regard. Exosomes facilitate skin cell proliferation and migration by transferring growth factors and signaling molecules. (Please note that exosomes are currently not approved by the Food and Drug Administration (FDA) to treat or diagnose any disease).
Author Interviews, Heart Disease, Stem Cells / 13.11.2023

MedicalResearch.com Interview with: [caption id="attachment_61040" align="alignleft" width="92"]Prof. Dr. Wolfram-Hubertus ZimmermannDirector, Institute of Pharmacology and Toxicology University Medical Center Göttingen Georg-August University Göttingen, Germany Dr. Zimmermann[/caption] Prof. Dr. Wolfram-Hubertus Zimmermann Director, Institute of Pharmacology and Toxicology University Medical Center Göttingen Georg-August University Göttingen, Germany   MedicalResearch.com: What is the background for this study? Response: Involvement in research and development in the field of tissue engineered heart repair since 25+ years. Bench-to-bed translation of our research. MedicalResearch.com: How are the stem cell obtained? Response: We make use of induced pluripotent stem cells as starting material to obtain heart muscle cells for the engineering of Engineered Human Myocardium (EHM) and its use as Biological Ventricular Assist Tissue (BioVAT).
Author Interviews, Brigham & Women's - Harvard, Endocrinology, Fertility, Lancet, OBGYNE / 25.07.2023

MedicalResearch.com Interview with: [caption id="attachment_60669" align="alignleft" width="150"]Raymond M. Anchan, MD, Ph.D.Director, Stem Cell Biology and Regenerative Medicine Research Laboratory Assistant Professor, Harvard Medical School Obstetrics/Gynecology Center for Infertility and Reproductive Surgery Brigham and Women's Hospital Dr. Anchan[/caption] Raymond M. Anchan, MD, Ph.D. Director, Stem Cell Biology and Regenerative Medicine Research Laboratory Assistant Professor, Harvard Medical School Obstetrics/Gynecology Center for Infertility and Reproductive Surgery Brigham and Women's Hospital MedicalResearch.com: What is the background for this study? Response: As a reproductive endocrinologist, I have the privilege of caring for patients who unfortunately experience premature ovarian insufficiency- Some of these patients are as young as 17 yo. Additionally, a significant number of patients over the years have been reproductive age women who have breast cancer and ovarian failure from chemotherapy.  These patients have been my inspiration to try to find a treatment for them.  Since my earlier days as a neurobiologist and stem cell scientist, it was a natural course for me to seek cell-based therapies that are patient specific using autologous iPSCs.
Author Interviews, Nature, Stem Cells / 05.09.2022

MedicalResearch.com Interview with: [caption id="attachment_59492" align="alignleft" width="150"]Gianluca Amadei PhD Post-Doctoral Fellow University of Cambridge, UK Dr. Amadei[/caption] Gianluca Amadei PhD Post-Doctoral Fellow University of Cambridge, UK MedicalResearch.com: What is the background for this study? What are the main findings? Response: The background of this study is that we tried to build a structure that looks and develops like a real mouse embryo using different kinds of mouse stem cells. The main findings are that the resulting structures develop the entire embryonic body axis and the extraembryonic tissues that are required to support embryonic development. Our structures develop to a stage comparable to 8.5 days of embryonic development of the natural mouse embryos and have a brain and neural tube, a beating heart-like structure, gut and primordial germ cells.
Thank you for visiting MedicalResearch.com Senior Editor, Marie Benz MD. For more information please email: info@MedicalResearch.com

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.